Tracheoesophageal fistula and esophageal perforation in a patient with advanced gastroesophageal junction tumor post ramucirumab treatment. A case report and literature review
Authors:
- Ahmed AbdalhadiAAAhmed Abdalhadi
- Mouhammad J AlawadMAMouhammad J Alawad
- Nabil E. OmarNONabil E. Omar
- Muhammed HajmusaMHMuhammed Hajmusa
- Mohammed GaberMGMohammed Gaber
- Alaaeldin ShablakASAlaaeldin Shablak
Open Access
- 21 December 2022
- journal article
- review article
- Published by Elsevier in Current Problems in Cancer: Case Reports
- Vol. 9
Abstract
No abstract availableKeywords
Funding Information
- Qatar National Library
This publication has 19 references indexed in Scilit:
- Treatment of Malignant Tracheoesophageal FistulaThoracic Surgery Clinics, 2014
- Side effects of anti-angiogenic drugsThrombosis Research, 2012
- Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforationInvestigational New Drugs, 2008
- Thieme atlas of anatomyChoice Reviews Online, 2008
- Adenocarcinoma of the Gastroesophageal JunctionAnnals of Surgery, 2007
- What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?Gynecologic Oncology, 2007
- Gastrointestinal Perforation Due to Bevacizumab in Colorectal CancerAnnals of Surgical Oncology, 2007
- Bevacizumab-Induced Cardiovascular Events: A Consequence of Cholesterol Emboli Syndrome?JNCI: Journal of the National Cancer Institute, 2007
- Management of spontaneous perforation of esophageal cancer with covered self expanding metallic stentsDiseases of the Esophagus, 2005
- Spontaneous gastroduodenal perforation in patients with cancer receiving chemotherapy and steroids. Report of four cases combining 5-fluorouracil infusion and cisplatin with antiemetics dexamethasoneCancer, 1993